Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 359

1.

Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size.

Rossi S, Gasparotto D, Toffolatti L, Pastrello C, Gallina G, Marzotto A, Sartor C, Barbareschi M, Cantaloni C, Messerini L, Bearzi I, Arrigoni G, Mazzoleni G, Fletcher JA, Casali PG, Talamini R, Maestro R, Dei Tos AP.

Am J Surg Pathol. 2010 Oct;34(10):1480-91. doi: 10.1097/PAS.0b013e3181ef7431. Erratum in: Am J Surg Pathol. 2011 May;35(5):781. Maestra, Roberta [corrected to Maestro, Roberta].

PMID:
20861712
2.

Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.

Miettinen M, Sobin LH, Lasota J.

Am J Surg Pathol. 2009 Sep;33(9):1267-75. doi: 10.1097/PAS.0b013e3181a13e99.

PMID:
19440146
3.

The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).

Du CY, Shi YQ, Zhou Y, Fu H, Zhao G.

J Surg Oncol. 2008 Sep 1;98(3):175-8. doi: 10.1002/jso.21104.

PMID:
18618605
4.

V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.

Agaimy A, Terracciano LM, Dirnhofer S, Tornillo L, Foerster A, Hartmann A, Bihl MP.

J Clin Pathol. 2009 Jul;62(7):613-6. doi: 10.1136/jcp.2009.064550.

PMID:
19561230
5.

Site-dependent differential KIT and PDGFRA expression in gastric and intestinal gastrointestinal stromal tumors.

Haller F, Happel N, Schulten HJ, von Heydebreck A, Schwager S, Armbrust T, Langer C, Gunawan B, Doenecke D, Füzesi L.

Mod Pathol. 2007 Oct;20(10):1103-11.

6.

Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site.

Wasag B, Debiec-Rychter M, Pauwels P, Stul M, Vranckx H, Oosterom AV, Hagemeijer A, Sciot R.

Mod Pathol. 2004 Aug;17(8):889-94.

7.

[c-kit and PDGFRA mutations in 60 cases of gastrointestinal stromal tumors (GISTs)].

He HY, Xiang YN, Li Y, Zhong HH, Wu BQ, Zheng J.

Beijing Da Xue Xue Bao. 2005 Jun 18;37(3):320-4. Chinese.

8.

Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations.

Agaimy A, Wünsch PH, Hofstaedter F, Blaszyk H, Rümmele P, Gaumann A, Dietmaier W, Hartmann A.

Am J Surg Pathol. 2007 Jan;31(1):113-20.

PMID:
17197927
9.

Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases.

Lasota J, Corless CL, Heinrich MC, Debiec-Rychter M, Sciot R, Wardelmann E, Merkelbach-Bruse S, Schildhaus HU, Steigen SE, Stachura J, Wozniak A, Antonescu C, Daum O, Martin J, Del Muro JG, Miettinen M.

Mod Pathol. 2008 Apr;21(4):476-84. doi: 10.1038/modpathol.2008.2.

10.

Genetic and pathologic characteristics of gastrointestinal stromal tumors in extragastric lesions.

Cho S, Kitadai Y, Yoshida S, Tanaka S, Yoshihara M, Yoshida K, Chayama K.

Int J Mol Med. 2006 Dec;18(6):1067-71.

PMID:
17089009
11.

The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.

Penzel R, Aulmann S, Moock M, Schwarzbach M, Rieker RJ, Mechtersheimer G.

J Clin Pathol. 2005 Jun;58(6):634-9.

12.
13.

Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.

Zheng S, Chen LR, Wang HJ, Chen SZ.

Hepatogastroenterology. 2007 Dec;54(80):2285-90.

PMID:
18265649
14.

KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.

Yamamoto H, Kojima A, Nagata S, Tomita Y, Takahashi S, Oda Y.

Am J Surg Pathol. 2011 Sep;35(9):1287-95. doi: 10.1097/PAS.0b013e3182206f15.

PMID:
21836495
15.
16.

[Status and clinical analysis of c-kit and PDGFRA mutations in the gastrointestinal stromal tumors].

Du CY, Shi YQ, Zhou Y, Fu H, Zhao GF.

Zhonghua Wei Chang Wai Ke Za Zhi. 2008 Jul;11(4):371-5. Chinese.

PMID:
18636362
17.

Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients.

Kang DY, Park CK, Choi JS, Jin SY, Kim HJ, Joo M, Kang MS, Moon WS, Yun KJ, Yu ES, Kang H, Kim KM.

Am J Surg Pathol. 2007 Feb;31(2):224-32.

PMID:
17255767
18.

Pathological characteristics of gastrointestinal stromal tumours with PDGFRA mutations.

Kwon JE, Kang HJ, Kim SH, Lee YC, Hyung WJ, Noh SH, Kim NK, Kim H.

Pathology. 2009;41(6):544-54.

PMID:
19900103
19.

Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature.

Prakash S, Sarran L, Socci N, DeMatteo RP, Eisenstat J, Greco AM, Maki RG, Wexler LH, LaQuaglia MP, Besmer P, Antonescu CR.

J Pediatr Hematol Oncol. 2005 Apr;27(4):179-87. Review.

PMID:
15838387
20.

The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs.

Sápi Z, Füle T, Hajdu M, Matolcsy A, Moskovszky L, Márk A, Sebestyén A, Bodoky G.

Diagn Mol Pathol. 2011 Mar;20(1):22-33. doi: 10.1097/PDM.0b013e3181eb931b.

PMID:
21326036
Items per page

Supplemental Content

Support Center